Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 28, 2011
Patent Application Number
12930661
Date Filed
January 12, 2011
Patent Primary Examiner
Patent abstract
Described are of recombinant adenoviral vectors in vaccination regimens, such as prime/boost set-ups and subsequent vaccinations and applications for gene therapy. Moreover, described are assays to determine the best regimen for applying the most suitable recombinant viral vector in a vaccination or gene therapy setting.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
